logo logo


mexedrone  is a stimulant medication of the cathinone class that has been sold online as an architect drug.[1][2] It is the alpha-methoxy subsidiary of Mephedrone.


Mexedrone goes about as a feeble serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) with IC50 estimations of 5289 nM, 8869 nM and 6844 nM, separately, and also a powerless serotonin discharging specialist (SRA) with an EC50 estimation of 2525 nM.[3]


Lawful status

Mexedrone is illicit in Sweden starting at 26. January 2016[4] and also Japan starting at 24. August 2016.[5]

See also





“Mexedrone”. New Engineered Medication Database.

Bounce up ^ Qian, Zhenhua; Jia, Wei; Li, Tao; Liu, Cuimei; Hua, Zhendong (2016). “ID and diagnostic portrayal of four manufactured cathinone subordinates iso-4-BMC, β-TH-naphyrone, mexedrone, and 4-MDMC”. Medication Testing and Examination. ISSN 1942-7611. PMID 27352812. doi:10.1002/dta.1983.

Bounce up ^ McLaughlin, Gavin; Morris, Noreen; Kavanagh, Puncture V.; Power, John D.; Dowling, Geraldine; Twamley, Brendan; O’Brien, John; Talbot, Brian; Walther, Donna; Partilla, John S.; Baumann, Michael H.; Brandt, Simon D. (2016). “Amalgamation, portrayal and monoamine transporter movement of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone”. Medication Testing and Examination. ISSN 1942-7611. PMID 27524685. doi:10.1002/dta.2053.

Hop up ^ “31 nya ämnen kan klassas som narkotika eller hälsofarlig vara” (in Swedish). Folkhälsomyndigheten. November 2015.

Hop up ^ “指定薬物一覧” (PDF) (in Japanese). Service of Wellbeing, Work and Welfare


Comments are closed.